Skip to main content
. 2023 Mar 10;5(10):223–228. doi: 10.46234/ccdcw2023.041

Table S1. Hesitancy to receive COVID-19 vaccine booster doses and descriptive statistics of independent variables of interest (among 525 participants who completed the primary vaccination series).

Hesitancy to receive COVID-19 vaccine booster doses and individual-level variables No. of participants Percentage (%)
Abbreviation: COVID-19=coronavirus disease 2019; SD=standard deviation.
* Positive Attitude Scale. 3 items. Cronbach’s alpha: 0.90. Exploratory factor analysis identified one factor, explaining 83.38% of total variance.
Negative Attitude Scale. 5 items. Cronbach’s alpha: 0.84. Exploratory factor analysis identified one factor, explaining 72.05% of total variance.
§ Media Exposure Scale, 4 items, Cronbach’s alpha: 0.90, one factor was identified by exploratory factor analysis, explaining 76.39% of total variance.
Hesitancy to receive COVID-19 vaccine booster doses
Uptake of the first COVID-19 vaccine booster dose (the third dose)
No 263 50.1
Yes 262 49.9
Behavioral intention to receive the first COVID-19 vaccine booster dose (among participants who had not received it, n=263)
Likelihood of outcomes: unlikely to neutral 168 63.9
Highly probable 95 36.1
Hesitancy to receive the first COVID-19 vaccine booster dose (the third dose)
No 357 68.0
Yes 168 32.0
Hesitancy to receive the second COVID-19 vaccine booster dose (the fourth dose)
No 229 43.6
Yes 296 56.4
Individual-level variables
Positive attitudes toward COVID-19 vaccine booster dose, n (%) agree/strongly agree
Receiving a booster dose can maintain your antibody level and strengthen the protection against COVID-19 289 51.2
A booster dose is highly effective in protecting you from COVID-19 variants of concern (e.g., Omicron) 190 36.2
A booster dose is highly effective in preventing severe consequences of COVID-19 253 48.2
Positive attitude scale*, Mean (SD) 10.8 (2.1)
Negative attitudes toward COVID-19 vaccine booster dose, n (%) agree/strongly agree
The protection offered by COVID-19 vaccine booster dose is weaker among people with cancers 184 35.0
Cancer therapy would reduce the protection of COVID-19 vaccine booster dose 167 31.8
The side effects of COVID-19 vaccine booster dose are more severe among people with cancers 195 37.1
The duration of protection of COVID-19 vaccine booster dose is shorter among people with cancers 101 19.2
COVID-19 vaccine booster dose would negatively affect the control of cancers 191 36.4
Negative attitude scale, Mean (SD) 16.1 (4.0)
Perceived subjective norm related to COVID-19 vaccine booster dose, n (%), agree/strongly agree
People who are important to you, such as family members or healthcare providers, would likely support you in receiving a booster dose 190 36.2
Item score, Mean (SD) 3.2 (0.9)
Perceived behavioral control to receive a COVID-19 vaccine booster dose, agree/strongly agree
Receiving a COVID-19 vaccine booster dose is easy for you if you want to 253 48.2
Item score, Mean (SD) 3.4 (0.9)
Vaccination fatigue: n (%) agree/strongly agree
You are tired of receiving COVID-19 vaccination over and over again 90 17.1
Item score, Mean (SD) 2.5 (1.3)
Media influences related to COVID-19 and COVID-19 vaccination
Frequency of exposure to the following contents on TV, radio, newspaper, and internet, n (%) sometimes/always
Infectivity of the Omicron variant of COVID-19 407 77.5
Risk of having severe consequences or death is relatively low following infection of the Omicron variant of COVID-19 341 65.0
COVID-19 pandemic is not under control after COVID-19 vaccination rollout 283 53.9
Some people contract COVID-19 after completion of their primary vaccine series 314 59.8
Media exposure scale§, Mean (SD) 11.1 (3.4)
Frequency of thoughtful consideration about veracity of COVID-19-specific information
Almost never 102 19.4
Seldom 108 20.6
Sometimes 206 39.2
Always 109 20.8
Item score, Mean (SD) 2.6 (1.0)